US HEVA Oncology and Rare Team Lead
Sanofi
June 28, 2026
Remote friendly (Morristown, NJ)
United States
$206,250 - $297,916.66 USD yearly
Sales
Main Responsibilities
- Lead US HEOR strategy and execution for Oncology and Rare Therapeutic Areas across indications; ensure generation, translation, and dissemination of high-quality, decision-relevant evidence to impact US access.
- Drive measurable business impact through strategic US HEVA initiatives aligned to US commercial objectives and market access goals.
- Develop and execute US HEVA strategies aligned with Global HEVA; partner with Commercial to translate HEVA insights into actionable business strategies.
- Provide leadership to the US Oncology and Rare HEVA team; mentor and develop talent; drive organizational change and process improvements.
- Build cross-functional relationships to support pricing/access decisions using robust evidence (including real-world evidence).
- Present recommendations to senior leadership; communicate complex health economics clearly; influence key business decisions with data-driven HEVA insights.
- Oversee health economics and outcomes research: design, execution, publication, dissemination; develop real-world evidence strategies; ensure scientific rigor and regulatory compliance.
- Manage US launch strategy and evidence generation plans, including input into Integrated Evidence Generation Plans (IEGPs).
- Lead HEOR dissemination and appropriate proactive/promotional use with US stakeholders (e.g., HCEI, PIE, consistent with FDA label); partner with Medical Affairs and Value & Access for field use/training.
- Lead payer partnership health economics/outcomes research and analytics with Access Strategy/US Market Access.
- Engage external stakeholders (payers, HTA bodies, academic institutions); represent Sanofi at conferences; engage evidence bodies (e.g., ICER, PDAB, IRA).
Requirements
- Minimum 10 years in health economics, outcomes research, or related field.
- PhD, PharmD, or equivalent in health economics, epidemiology, public health, economics, or related.
- Demonstrated expertise in health economic modeling, real-world evidence generation, and outcomes research methods.
- Deep US healthcare/payer policy expertise; proven ability to translate evidence into strategic impact and support market access/reimbursement.
- Strong US evidence dissemination experience (HCEI/PIE, reactive/proactive, CFL, AMCP dossiers).
- Exceptional leadership; change management; cross-functional influence.
- Extensive oncology or rare therapeutic area experience.
- Strong English communication; ability to synthesize complex data into actionable insights.
Benefits
- Health and wellbeing benefits including high-quality healthcare, prevention and wellness programs, and at least 14 weeks’ gender-neutral parental leave.
- Lead US HEOR strategy and execution for Oncology and Rare Therapeutic Areas across indications; ensure generation, translation, and dissemination of high-quality, decision-relevant evidence to impact US access.
- Drive measurable business impact through strategic US HEVA initiatives aligned to US commercial objectives and market access goals.
- Develop and execute US HEVA strategies aligned with Global HEVA; partner with Commercial to translate HEVA insights into actionable business strategies.
- Provide leadership to the US Oncology and Rare HEVA team; mentor and develop talent; drive organizational change and process improvements.
- Build cross-functional relationships to support pricing/access decisions using robust evidence (including real-world evidence).
- Present recommendations to senior leadership; communicate complex health economics clearly; influence key business decisions with data-driven HEVA insights.
- Oversee health economics and outcomes research: design, execution, publication, dissemination; develop real-world evidence strategies; ensure scientific rigor and regulatory compliance.
- Manage US launch strategy and evidence generation plans, including input into Integrated Evidence Generation Plans (IEGPs).
- Lead HEOR dissemination and appropriate proactive/promotional use with US stakeholders (e.g., HCEI, PIE, consistent with FDA label); partner with Medical Affairs and Value & Access for field use/training.
- Lead payer partnership health economics/outcomes research and analytics with Access Strategy/US Market Access.
- Engage external stakeholders (payers, HTA bodies, academic institutions); represent Sanofi at conferences; engage evidence bodies (e.g., ICER, PDAB, IRA).
Requirements
- Minimum 10 years in health economics, outcomes research, or related field.
- PhD, PharmD, or equivalent in health economics, epidemiology, public health, economics, or related.
- Demonstrated expertise in health economic modeling, real-world evidence generation, and outcomes research methods.
- Deep US healthcare/payer policy expertise; proven ability to translate evidence into strategic impact and support market access/reimbursement.
- Strong US evidence dissemination experience (HCEI/PIE, reactive/proactive, CFL, AMCP dossiers).
- Exceptional leadership; change management; cross-functional influence.
- Extensive oncology or rare therapeutic area experience.
- Strong English communication; ability to synthesize complex data into actionable insights.
Benefits
- Health and wellbeing benefits including high-quality healthcare, prevention and wellness programs, and at least 14 weeks’ gender-neutral parental leave.